Clinical trial
A Multicenter Prospective Observational Study to Evaluate Cytomegalovirus (CMV)-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients With CMV-positive Serology (R+) Prior to Transplant and Its Involvement in the Development of CMV Infection
NCT02076971 is registered in ClinicalTrials.gov with Fundacio Catalana de Pneumologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Prospective Observational Study to Evaluate Cytomegalovirus (CMV)-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients With CMV-positive Serology (R+) Prior to Transplant and Its Involvement in the Development of CMV Infection
- Lead sponsor
- Fundacio Catalana de Pneumologia
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- March 31, 2016
- Enrollment
- 92 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.